The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.

by Christopher H Lieu, Hai Tran, Zhi-Qin Jiang, Muling Mao, Michael J Overman, E Lin, Cathy Eng, Jeffrey Morris, Lee Ellis, John V Heymach, Scott Kopetz
Published 2013-01-01

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

by Sarah J. Hartman, Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu, S. Lindsey Davis, Alexis D. Leal, John J. Tentler, Jennifer R. Diamond, S. Gail Eckhardt, Wells A. Messersmith, Todd M. Pitts
Published 2021-03-01

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

by Juan A. Marín-Jiménez, Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro, Hui Yu, Hui Yu, Chris J. Rivard, Chris J. Rivard, Xiaoguang Wang, Jessica C. Barkow, Degui Geng, Adwitiya Kar, Ashley Yingst, Dejene M. Tufa, James T. Dolan, Patrick J. Blatchford, Brian M. Freed, Brian M. Freed, Raul M. Torres, Raul M. Torres, Eduardo Davila, Eduardo Davila, Jill E. Slansky, Jill E. Slansky, Roberta Pelanda, Roberta Pelanda, S. Gail Eckhardt, Wells A. Messersmith, Wells A. Messersmith, Jennifer R. Diamond, Jennifer R. Diamond, Christopher H. Lieu, Michael R. Verneris, Jing H. Wang, Jing H. Wang, Katja Kiseljak-Vassiliades, Katja Kiseljak-Vassiliades, Todd M. Pitts, Todd M. Pitts, Julie Lang
Published 2021-03-01